NUPCO signs over 15 new MoUs at the Global Health Exhibition 2024, deepening its ties with the private sector and advancing ...

The insulin is facing supply shortages as diabetes patients increasingly turn to GLP-1 weight loss drugs such as Ozempic and ...

Saudi Arabia signed an agreement to produce at least seven insulin products locally, enhancing its pharmaceutical ...

The global insulin pens market is witnessing unprecedented growth, propelled by the escalating prevalence of diabetes worldwide. According to recent industry reports, the market, valued at USD 35 ...

The Global Health Exhibition 2024 witnessed today, Oct. 22, the signing of a final agreement to localize the production of ...

As part of new agreements announced at the 7th edition of the Global Health Forum, Saudi Arabia signed deals to localize the ...

Diabetes is a global health concern, making it essential to ensure a continuous and reliable supply of high-quality insulin ...

The settlement announced by Attorney General Bridget Hill on Friday morning with Sanofi-Aventis U.S. will be put into effect within 90 days of Sept. 27. The cost of insulin has soared over the ...

Novo Nordisk May Proceed with Its Ozempic Suit Against DCA Pharmacy. A Tennessee federal court denied DCA Pharmacy’s motion ...

The global market for diabetes care devices is forecast to reach US $16 billion by 2030 with a growing compound annual growth rate (CAGR) of 6.5% during the forecast period 2021-2030. In 2020, the ...

Wyoming’s attorney general, through a settlement with a French multinational pharmaceutical and healthcare company, has ...

Eighty states, cities, counties, school boards and unions have joined litigation in a New Jersey district court against the three major pharmacy middlemen.